Acclinate

Birmingham, AL · Founded 2020 · Privately Held (backing)

Developer of a digital health platform designed to facilitate an increase in representation and diversity of their genomic research and clinical trials. Acclinate is based in Birmingham, AL and was founded in 2020. Its last reported valuation was $40 million in May 2024. It has raised $15.6 million across 3 recorded rounds; the latest was a $3.5 million seed round in Feb 2026.

Last reported valuation
$40.0M
Oct 2026
Priced at
—
Total raised
$15.6M
Last round
Seed Round
Feb 2026
What is Acclinate worth?
$40.0Mlast reported valuation · Oct 2026

Acclinate's last reported valuation, May 2024. Nothing priced has surfaced since.

Free account
More of Acclinate with a free account
  • ·The complete investor list: 24 names
  • ·Watch Acclinate: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

Acclinate funding history

3 rounds
DateRoundRaisedPost-money
Feb 2026Seed Round$3.5M▮
May 2024Early Stage VC$6.0M▮
Oct 2022Seed Round$4.9M▮
Unlock post-money valuations

Membership and data by Private Market View

Acclinate valuation

Acclinate's last reported valuation was $40 million in May 2024. No priced round, secondary trade or fund mark has surfaced since.

How much has Acclinate raised?

Acclinate has raised $15.6 million across 3 recorded rounds since 2022. The largest was a $6 million early-stage round in May 2024; the most recent was a $3.5 million seed round in Feb 2026.

Acclinate has filed 3 Form Ds with the SEC since 2022, most recently in Apr 2026 ($3.5 million sold to 5 investors).

How Acclinate's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Acclinate, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by last reported valuation. Question about this number? Full methodology →

Frequently asked about Acclinate

What is Acclinate worth?
Acclinate is valued at $40.0M as of Oct 2026. Acclinate's last reported valuation, May 2024. Nothing priced has surfaced since.
How much has Acclinate raised?
Acclinate has raised $15.6M in total funding across 3 recorded rounds.
When did Acclinate last raise?
Acclinate last raised in Feb 2026 (Seed Round), raising $3.5M.